Regent’s Park awarded a contract to provide a PCI Modular Cath Lab in South London
Regent’s Park Cardiovascular Solutions Ltd. (Regent’s Park), an independent healthcare company specialising in the provision of infrastructure solutions to the NHS, today announced it have been awarded a contract to provide a specialist PCI & cardiac devices modular cath lab to Croydon University Hospital in South London.
Daniel Oberholzer, Corporate Development Director of Regent’s Park said: “We are very pleased to have won this competitive tender and to break into the London cath lab arena. The award will add to our nationwide network of specialist cardiology facilities and confirm our position as the UK’s leading independent cardiology services provider. The award fits extremely well with our strategy of working with growing NHS hospitals to improve the access and quality of cardiac care to local communities. We all look forward to the privilege of working with the cardiologists and staff at Croydon University Hospital.”
Regent’s Park Heart Clinics ltd. and Regent’s Park Cardiovascular Solutions Ltd. are independent companies dedicated to creating world-class centres for the diagnosis and treatment of heart disease. Regent’s Park develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom.
Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 20,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, transcatheter aortic valve implantations, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.
The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.